Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 5128720, 8 pages
http://dx.doi.org/10.1155/2016/5128720
Research Article

Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades

1Department of Cell Signaling, Institute of Molecular Biology and Genetics NASU, Kyiv, Ukraine
2Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia
3Breast Cancer Department, National Cancer Institute, Kyiv, Ukraine
4Department of Oncological Pathology, Dnipropetrovsk Regional Center of Pathology, Dnipropetrovsk, Ukraine

Received 20 June 2016; Revised 30 August 2016; Accepted 29 September 2016

Academic Editor: Szilárd Nemes

Copyright © 2016 Lada Dyachenko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Bleyer and H. G. Welch, “Effect of three decades of screening mammography on breast-cancer incidence,” The New England Journal of Medicine, vol. 367, no. 21, pp. 1998–2005, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Weigelt, F. C. Geyer, and J. S. Reis-Filho, “Histological types of breast cancer: how special are they?” Molecular Oncology, vol. 4, no. 3, pp. 192–208, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. N. T. Brewer, T. Salz, and S. E. Lillie, “Systematic review: the long-term effects of false-positive mammograms,” Annals of Internal Medicine, vol. 146, no. 7, pp. 502–510, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Coolen, K. Leunen, J. Menten, W. van Steenbergen, and P. Neven, “False-negative tests in breast cancer management,” Netherlands Journal of Medicine, vol. 69, no. 7, pp. 324–329, 2011. View at Google Scholar · View at Scopus
  5. C. Desmetz, A. Mange, T. Maudelonde, and J. Solassol, “Autoantibody signatures: progress and perspectives for early cancer detection,” Journal of Cellular and Molecular Medicine, vol. 15, no. 10, pp. 2013–2024, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Lu and V. Goodell, “Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer,” Journal of Proteome Research, vol. 45, pp. 88–94, 2008. View at Google Scholar
  7. E. Piura and B. Piura, “Autoantibodies to tailor-made panels of tumor-associated antigens in breast carcinoma,” Journal of Oncology, vol. 2011, Article ID 982425, 7 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Looi, R. Megliorino, F.-D. Shi, X.-X. Peng, Y. Chen, and J.-Y. Zhang, “Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies,” Oncology Reports, vol. 16, no. 5, pp. 1105–1110, 2006. View at Google Scholar · View at Scopus
  9. A. Yagihashi, T. Ohmura, K. Asanuma et al., “Detection of autoantibodies to survivin and livin in sera from patients with breast cancer,” Clinica Chimica Acta, vol. 362, no. 1-2, pp. 125–130, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. O. Garifulin, V. Kykot, N. Gridina et al., “Application of SEREX-analysis on colon cancer cases,” Experimental Oncology, vol. 2, pp. 128–131, 2003. View at Google Scholar
  11. R. Kiyamova, O. Garifulin, V. Gryshkova et al., “Preliminary study of thyroid and colon cancers-associated antigens and their cognate autoantibodies as potential cancer biomarkers,” Biomarkers, vol. 17, no. 4, pp. 362–371, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Kiyamova, O. Kostianets, S. Malyuchik et al., “Identification of tumor-associated antigens from medullary breast carcinoma by a modified SEREX approach,” Molecular Biotechnology, vol. 46, no. 2, pp. 105–112, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. R. G. Kyyamova and V. V. Filonenko, “Tumor-associated antigens and development of immunotherapeutics strategies,” Biopolymers and Cell, vol. 21, no. 3, pp. 220–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. C. S. Klade, “Proteomics approaches towards antigen discovery and vaccine development,” Current Opinion in Molecular Therapeutics, vol. 4, no. 3, pp. 216–223, 2002. View at Google Scholar · View at Scopus
  15. O. Kostianets, M. Shyian, D. Sergiy et al., “Serological analysis of SEREX-defined medullary breast carcinoma-associated antigens,” Cancer Investigation, vol. 30, no. 7, pp. 519–527, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. N. V. Rodnin, I. O. Tykhonkova, R. G. Kyyamova, O. M. Garifulin, I. T. Gout, and V. V. Filonenko, “Identification of tumor-associated antigens in human thyroid papillar carcinoma,” Biopolymers & Cell, vol. 19, no. 6, pp. 541–547, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Shyian, O. I. Kostianets, O. Y. Tsuvariev et al., “The peculiarities of gene expression of medullary breast carcinoma tumor-associated antigens in different types of breast tumors,” Biopolymers and Cell, vol. 28, no. 5, pp. 381–388, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Tavassoli and P. Devilee, World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Breast and Female Genital Organs, vol. 5, IARC Press, Lyon, France, 2003.
  19. A. O. Güre, E. Stockert, M. J. Scanlan et al., “Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 8, pp. 4198–4203, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. M. J. Scanlan, I. Gout, C. M. Gordon et al., “Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression,” Cancer Immunity, vol. 1, pp. 4–21, 2001. View at Google Scholar · View at Scopus
  21. Y. Obata, T. Takahashi, J. Sakamoto et al., “Serex analysis of gastric cancer antigens,” Cancer Chemotherapy and Pharmacology, vol. 46, supplement 1, pp. S37–S42, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Greiner, M. Ringhoffer, M. Taniguchi et al., “Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia,” International Journal of Cancer, vol. 106, no. 2, pp. 224–231, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Adrien, K.-H. Ludger, S. Ingo et al., “Malignant fibrous histiocytoma-pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A Pilot Study,” Langenbeck's Archives of Surgery, vol. 395, no. 3, pp. 261–275, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Gromadka and J. Rytka, “The KRR1 gene encodes a protein required for 18S rRNA synthesis and 40S ribosomal subunit assembly in Saccharomyces cerevisiae,” Acta Biochimica Polonica, vol. 47, no. 4, pp. 993–1005, 2000. View at Google Scholar · View at Scopus
  25. H. A. Hundley, W. Walter, S. Bairstow, and E. A. Craig, “Human Mpp11 J protein: ribosome-tethered molecular chaperons are ubiquitous,” Science, vol. 308, no. 5724, pp. 1032–1034, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Richly, L. Rocha-Viegas, J. D. Ribeiro et al., “Transcriptional activation of polycomb-repressed genes by ZRF1,” Nature, vol. 468, pp. 1124–1128, 2010. View at Publisher · View at Google Scholar
  27. V. A. Resto, O. L. Caballero, M. R. Buta et al., “A putative oncogenic role for MPP11 in head and neck squamous cell cancer,” Cancer Research, vol. 60, no. 19, pp. 5529–5535, 2000. View at Google Scholar · View at Scopus
  28. A. Marchet, S. Mocellin, C. Belluco et al., “Gene expression profile of primary gastric cancer: towards the prediction of lymph node status,” Annals of Surgical Oncology, vol. 14, no. 3, pp. 1058–1064, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Demajo, I. Uribesalgo, A. Gutiérrez et al., “ZRF1 controls the retinoic acid pathway and regulates leukemogenic potential in acute myeloid leukemia,” Oncogene, vol. 33, pp. 5501–5510, 2014. View at Publisher · View at Google Scholar · View at Scopus